Industry
DPC Granted License to Develop Cancer Diagnostics
A license to develop and commercialize diagnostic assays based on two novel prostate-specific proteins for detecting and monitoring prostate cancer and perhaps other cancers has been granted to Diagnostic Products Corp. by Compugen, Ltd. More...30 Nov -0001
SpectRx Regains Rights to Glucose Monitoring Technology
A research, development, and license agreement on continuous glucose monitoring technology with Abbott Laboratories has been terminated, according to an announcement by SpectRx, Inc., which has regained rights to the technology.More...
30 Nov -0001
Huge Growth in Asian In Vitro Diagnostic Markets
Revenues in the top five Asian clinical diagnostic markets are currently near US$3.5 billion, and double-digit growth is not uncommon in many segments now considered moribund in Western Europe and the United States, according to a new study More...30 Nov -0001
In Other News
Alliance to Market HPV Test
Continued Growth Seen for MEDICA 2002
Glucose Monitoring Program Continues
Alliance to Develop Clinical Diagnostics
DakoCytomation Acquires Artisan Line from CytoLogix
Alliance for Test to Detect Early Kidney Disease
Alliance to Develop Cancer Assays
Fujirebio Acquires Rights to Ovarian Tumor Markers
Bayer to Acquire Visible Genetics, Inc.
Digene Calls Off Merger with Cytyc
Trinity Biotech to Acquire Hemostasis Business
Dako and Cytomation Announce Merger
Alliance to Develop Molecular Diagnostics
New Drug Assay Technology Licensed
Orlando to Host AACC Annual Meeting
Impac Acquires Intellidata
Alliance on Nannoarray Protein Assays
Alliance to Develop NAT Diagnostic System
Sigma-Aldrich to Sell Diagnostics Business
Bio-Rad Acquires Scottish Diagnostic Company
Collaboration to Develop Neurodegenerative Tests
DPC Acquires Rights to Sperm Analyzer
$29 Billion In Vitro Diagnostics Market Seen for 2007
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.







